Value of brain natriuretic peptide in the perioperative follow-up of children with valvular disease by Tissières, Pierre et al.
Intensive Care Med (2008) 34:1109–1113
DOI 10.1007/s00134-008-1025-8 PEDIATRIC BRIEF REPORT
Pierre Tissières
Eduardo da Cruz
Walid Habre
Yacine Aggoun
Noury Mensi
Afksendyios Kalangos
Maurice Beghetti
Value of brain natriuretic peptide
in the perioperative follow-up of children
with valvular disease
Received: 5 March 2007
Accepted: 21 January 2008
Published online: 19 February 2008
© Springer-Verlag 2008
Electronic supplementary material
The online version of this article
(doi:10.1007/s00134-008-1025-8) contains
supplementary material, which is available
to authorized users.
P.T. was supported by research grants from
the Roche Research Foundation (131-2002)
and the University Hospitals of Geneva
Research Fund (PRD-03-I-18).
P. Tissières ()
University of Geneva Medical School,
CMU, ICU Research Laboratory,
Department of Microbiology and Molecular
Medicine,
Rue Michel-Servet 1, 1211 Geneva 4,
Switzerland
e-mail: Pierre.Tissieres@medecine.unige.ch
Tel.: +41-22-3795686
P. Tissières · E. da Cruz
Children’s University Hospital, Pediatric
and Neonatal Intensive Care Division,
Geneva, Switzerland
E. da Cruz · Y. Aggoun · M. Beghetti
Children’s University Hospital, Pediatric
Cardiology Unit, Department of Pediatrics,
Geneva, Switzerland
E. da Cruz
Children’s Hospital of Denver, Pediatric
Cardiac Intensive Care Unit, Section
of Pediatric Cardiology, Heart Institute,
Denver CO, USA
W. Habre
University Hospital, Pediatric Anesthesia
Unit,
Geneva, Switzerland
N. Mensi
University Hospital, Clinical Chemistry
Laboratory,
Geneva, Switzerland
A. Kalangos
University Hospital, Service of
Cardiovascular Surgery,
Geneva, Switzerland
Abstract Objective: To characterize
N-terminal pro-brain natriuretic pep-
tide (N-proBNP) and troponin I (TnI)
profile following mitral and/or aortic
valve surgery and to evaluate correla-
tions with echocardiography measures
and outcome criteria. Design and
setting: Prospective cross-controlled
study in a university children’s hospi-
tal. Patients: Twenty children with
acquired valvular disease requiring
valvular surgery. Interventions:
We prospectively studied clinical,
biochemical, and echocardiographic
characteristics at baseline and 6, 12,
24 h and 3–4 weeks postoperatively.
Results: TnI peaked 6 h after surgery
and remained elevated during the first
24 h. N-proBNP was significantly
lower 3–4 weeks after surgery than
during the perioperative period. Over-
all, N-proBNP was correlated with
the Pediatric Heart Failure Index,
left ventricle shortening fraction, left
atrium to aorta ratio, left ventricle
mass index, end-systolic wall stress,
and with outcome measures such as
inotropic score, duration of inotropic
support, and ICU length of stay.
Preoperative N-proBNP was signifi-
cantly more elevated in patients with
complicated outcome than in patients
with uneventful postoperative course.
Conclusions: In pediatric valvular
patients, perioperative N-proBNP is
a promising risk stratification pre-
dicting factor. It is correlated with
evolutive echocardiographic mea-
sures, need for inotropic support, and
ICU length of stay.
Keywords Pediatric ·
Heart failure · N-terminal pro-
brain natriuretic peptide · Troponin ·
Valvular surgery · Nesiritide
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Introduction
As the prognosis of children with congenital heart disease
improves, managing heart failure both perioperatively
and at an outpatient clinic requires sensitive and adapted
tools. Recently brain natriuretic peptide (BNP) was shown
to reliably identified adults and children with dyspnea
of cardiac origin and to be correlated with heart failure
severity [1]. Similarly to BNP, cardiac troponin I (TnI)
was shown to be correlated with postoperative outcome
following cardiac surgery [2–4]. However, no study has
compared plasma TnI and BNP values and analyzed
the relationship to outcome measures and recovery over
a prolonged timed period in a homogeneous pediatric
population.
This study compare the accuracy of N-proBNP and that
of TnI in characterizing the degree of heart failure sever-
ity and analyzed the correlation with standard echocardio-
graphic measurements and recovery following corrective
surgery in children with acquired valvular disease.
Patients and methods
Patient population and power analysis
The study was carried out among children referred to the
University Children’s Hospital of Geneva for corrective
surgery of acquired mitral and/or aortic valvular heart dis-
ease. Twenty patients, cross-controlled (α = 0.05, β = 0.20)
were recruited to identify a 33% decrease (standardized
effect size: 1.0) in the perioperative New York University
Pediatric Heart Failure Index (PHFI) indicating clinical
recovery [5]. Patient’s characteristics are presented in
the Electronic Supplementary Material (ESM Table 1).
Most patients were severely or mildly malnourished and
showed significant height and weight retardation. Eigh-
teen patients required mitral surgery (16 valve plasties,
2 mechanical valve replacements) associated in seven with
aortic valve surgery (five plasties, one homologous valve
replacement, one mechanical valve replacement) and in
one with tricuspid valve plasty. Two patients had isolated
aortic valve surgery (one homologous valve replacement
and one plasty). The study was approved by the internal
Institutional Review Board and subjects’ representatives
gave informed consent. Data were prospectively collected
and analyzed by a single observer (P.T.). No deaths
occurred intraoperatively, and one patient died 4.5 days
after surgery of terminal heart failure.
Outcome measurements
Short-term outcome was evaluated based on duration of
inotropic support, inotropic score and length of stay in
the pediatric ICU. Mean inotropic score was calculated
by adding the mean doses of dopamine and dobutamine
in micrograms per kilogram per minute and assigning an
arbitrary equivalent value of 10 µg kg–1 min–1 inotrope for
each 0.1 µg kg–1 min–1 epinephrine and 2 µg kg–1 min–1
inotrope equivalent value for each 0.1 µg kg–1 min–1
milrinone [6, 7]. Patients were classified as uneventful
postoperative course if they were weaned from inotropic
support within the first 24 h and/or discharged from the
ICU before 4 days, or else as complicated postoperative
course. A 4-days cutoff was chosen as corresponding to
the median ICU length of stay.
Echocardiography
All children underwent repeated (before and 24 h and
3–4 weeks after surgery) comprehensive transthoracic
two-dimensional segmental and Doppler echocardio-
graphic studies using a Vingmed System Five ultrasound
system. Echocardiographic examinations were matched
with TnI and BNP measures. Echocardiography left
ventricular shortening fraction (LVSF), end-systolic wall
stress (ESWS), left atrium to aorta diameter (LA/AO)
ratio, and left ventricular mass (LVM) were systematically
calculated as described in the ESM.
TnI, N-ProBNP measurements
Whole blood was collected on ice in a 4 ml lithium-
heparinized plastic tube (Vacutainer, Becton-Dickinson,
Plymouth, U.K.), immediately centrifuged (3000 rpm
for 15 minutes) and stored at –70 °C. TnI andN-ProBNP
were measured in all patients before and 6, 12, 24 h and
3–4 weeks after surgery. TnI (Access AccuTnI Troponin I
Assay, Access DXI 800, Beckman Coulter., Fullerton,
CA, USA) and N-proBNP (Elecsys proBNP, Elecsys
2010, Roche Diagnostic, Mannheim, Germany) were
analyzed according to manufacturer. TnI and N-proBNP
measures were kept blinded until the end of patients’
recruitment. Normal ranges were: TnI less than 0.04 µg/l,
and N-proBNP less than 299 ng/l (adapted from [8]).
Data analysis
Results are presented as range and median for continuous
variables and as proportion of total for categorical vari-
ables. The Wilcoxon rank sum test was applied to analyze
continuous variables between the two groups. Continuous
variables in patients in independent groups (e.g., patients
having an uncomplicated or a complicated postoperative
course) were compared using the Mann–Whitney U test.
Correlations were determined by Spearman’s rank cor-
relation coefficient. Reciever operating characteristic
curves were constructed using the following cutoff values:
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Table 1 Correlation and ROC curve area under the zone between
TnI, N-proBNP, and echocardiographic workup (AZ, area under
the zone as obtained from receiver operating characteristic curves;
PHFI, Pediatric Heart Failure Index; LVSF, left ventricle shortening
fraction; LA/Ao, left atrium to aorta diameter ratio; LVM, left
ventricle mass index; ESWS, end-systolic wall stress)
TnI N-proBNP
ρ p Az ρ p Az
PHFI –0.07 n.s. 0.351 0.57 0.0007 0.774
LVSF –0.52 < 0.0001 0.791 –0.37 0.008 0.679
LA/Ao ratio –0.09 n.s. 0.533 0.28 0.04 0.618
LVM index 0.03 n.s. 0.498 0.37 0.008 0.651
ESWS 0.03 n.s. 0.461 0.42 0.002 0.552
PHFI 4 (compensated heart failure under angiotensin-
converting enzyme inhibitors and diuretics with functional
effort limitation), LA/AO ratio 1.2, LVSF 28%, LVM
index 184 g, ESWS 40 × 103 dynes/cm2. Differences
with a p-value below 0.05 were considered statistically
significant. Data were processed using the SPSS version
15.0.1 for Windows software (SPSS, Chicago, IL, USA).
Results
Perioperative profiles
TnI peaked 6 h after surgery and remained elevated for the
first 24 h postoperatively (ESM Table 2). TnI was normal-
ized 3–4 weeks after surgery. N-proBNP kinetic failed to
show a significant modification in the early postoperative
period. However, it was significantly lower 3–4 weeks af-
ter surgery, although still remaining abnormally elevated.
LVSF, LVM index, and LA/Ao ratio showed an early (24 h)
modification from preoperative values. Although LA/Ao
ratio and LVM index normalized, LVSF was significantly
altered 24 h after surgery. End-systolic wall stress did not
change significantly over time.
N-proBNP was correlated with PHFI and echocar-
diographic measures. TnI was not correlated with any
parameter except LVSF. Construction of the receiver
operating characteristic curve showed closer correlation
of N-proBNP than TnI with PHFI and echocardiographic
measures (Table 1). In addition, preoperative N-proBNP
values were correlated with all outcome measures, such as
need for and duration of inotropic support (respectively,
ρ = 0.50, p = 0.031, and ρ = 0.55, p = 0.019) and length of
stay in ICU (ρ = 0.45, p = 0.045). Postoperative TnI and
N-proBNP levels were not associated with outcome with
the exception of 6-h postoperative N-proBNP level which
was correlated with inotropic score (ρ = 0.53, p = 0.022).
Because of the significant difference in N-proBNP
level between patients with complicated vs. uncomplicated
postoperative course (ESM Table 3), the postoperative
course of N-proBNP kinetic was analyzed in the two
subgroups (Fig. 1). Patients with uneventful postoperative
course showed a statistically significant early postopera-
Fig. 1 Postoperative N-proBNP kinetics and diuresis in patients
with complicated or uncomplicated outcome. N-proBNP data are
expressed as “fold” induction from preoperative value (baseline) 6,
12, 24 h and 3–4 weeks after surgery. * p < 0.03 vs. basal (Wilcoxon
signed rank test). Mean daily diuresis was measured from day 1 to
day 4 following surgery
tive increase in N-proBNP level, whereas patients with
complicated outcome displayed unchanged postoperative
N-proBNP values, and even a decreased values in one-half
of them (n = 5). Preoperative N-proBNP (Az = 0.789) was
better than TnI (Az = 0.556) in discriminating patients
with complicated outcome.
Discussion
The results of the present study demonstrate the supe-
riority of N-proBNP over TnI in reflecting clinical and
echocardiographic postoperative recovery of children
undergoing valvular surgery. Furthermore, it suggests that
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preoperative N-proBNP reflects postoperative myocardial
functional capacity, thus helping in the early identification
of patients who will require prolonged resources and/or
additional support.
BNP has recently emerged as a useful tool to evalu-
ate myocardial function and functional capacity and to
discriminate between cardiac and noncardiac disease [9].
BNP has various physiological effects. It reduces preload
by vasodilating the cardiovascular system, increases
glomerular filtration and sodium excretion, and suppresses
sympathetic activity [10–12]. In young adults and children
with congenital heart disease BNP level is associated with
the severity of heart failure [13]. In our study N-proBNP
was correlated with most echocardiographic measures,
confirming previous studies performed in adults with
valvular disease and in children with right heart disease.
In a recent study Logeart et al. [14] showed that BNP
accuracy was greater than that of TnI in identifying
right ventricle failure secondary to pulmonary embolism.
In adults the preoperative BNP level was shown to be
a strong predictor of postoperative complications and
1-year mortality [15, 16]. Our series showed a correlation
between baseline N-proBNP and inotropic score, duration
of inotropic support, and ICU length of stay, confirming
recent data in children with various congenital heart
defect [17].
Among pediatric series analyzing perioperative
BNP, postoperative BNP increase was not invariably
found [18–20]. Although Shih et al. [6] documented
a global increase in BNP level, they noted that 38% of the
children did not show a BNP peak at 12 h. Interestingly,
in our series patients with a less complex postoperative
course showed a statistically significant early (6 h) and
sustained (up to 24 h) increase in postoperative N-proBNP
values which was not found in patients with complicated
postoperative course (Fig. 1). Similarly, a number of
studies have demonstrated that adults with the most severe
chronic heart failure do not have increase in BNP level
during exercise [21–23]. Moreover, these show that BNP
release is correlated with a better functional capacity,
independently of other clinical parameters [23], and
a decrease in 2-year mortality [22]. In the present study
early postoperative decrease in N-proBNP levels occurred
in patients with the higher preoperative PHFI (ESM Table
3) undersigning the most severe heart failure. Reduction
in BNP production may occur as a result of overwhelmed
myocardial capacity to synthesize BNP in regard to the
advanced heart failure, as shown by Redfield et al. [24] in
an experimental model of chronic severe heart failure.
The interpretation of our results is limited by the
study design as power was calculated to reflect a definite
expected postoperative clinical improvement as previously
reported [5]. Therefore interpretation of the correlation
between TnI and outcome is limited by the study power.
However, although correlations are weak, superiority of
N-proBNP over TnI is unquestionable.
In conclusion, in pediatric valvular patients, perioper-
ative N-proBNP is a promising risk stratification predict-
ing factor. It is correlated with evolutive echocardiographic
measures, need for inotropic support, and ICU length of
stay. These findings suggest that N-proBNP kinetics reflect
postoperative myocardial functional capacity, thus helping
in the early identification of patients who will require pro-
longed or intensive therapy. In addition, these preliminary
results allow the hypothesis that a postoperative “BNP in-
sufficiency” is present in patients with the most severe car-
diac condition, helping in determining which patients may
benefit of exogenous BNP, nesiritide, therapy. Further clin-
ical and experimental studies are required.
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